Milestone® Pharmaceuticals to Present at Upcoming Conferences
Milestone Pharmaceuticals (NASDAQ: MIST) announced its participation in two upcoming healthcare conferences. CEO Joe Oliveto will conduct one-on-one meetings at the Wells Fargo Healthcare Conference in Boston (September 3-5, 2025) and deliver a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference in New York (September 8-10, 2025).
The H.C. Wainwright presentation will be webcast live on September 9 at 12:00 PM EDT, with a replay available for approximately 90 days on the company's website.
Milestone Pharmaceuticals (NASDAQ: MIST) ha annunciato la sua partecipazione a due prossimi convegni nel settore sanitario. Il CEO Joe Oliveto terrà incontri individuali al Wells Fargo Healthcare Conference a Boston (3-5 settembre 2025) e presenterà una relazione aziendale al H.C. Wainwright 27th Annual Global Investment Conference a New York (8-10 settembre 2025).
La presentazione a H.C. Wainwright sarà trasmessa in diretta web il 9 settembre alle 12:00 EDT, con una replica disponibile per circa 90 giorni sul sito web della società.
Milestone Pharmaceuticals (NASDAQ: MIST) anunció su participación en dos próximas conferencias del sector salud. El CEO Joe Oliveto mantendrá reuniones individuales en el Wells Fargo Healthcare Conference en Boston (3-5 de septiembre de 2025) y ofrecerá una presentación corporativa en el H.C. Wainwright 27th Annual Global Investment Conference en Nueva York (8-10 de septiembre de 2025).
La presentación en H.C. Wainwright se transmitirá en vivo por internet el 9 de septiembre a las 12:00 PM EDT, y la repetición estará disponible aproximadamente 90 días en la web de la compañía.
Milestone Pharmaceuticals (NASDAQ: MIST)는 다가오는 두 건의 헬스케어 컨퍼런스 참가를 발표했습니다. CEO 조 올리베토(Joe Oliveto)는 보스턴에서 열리는 Wells Fargo Healthcare Conference(2025년 9월 3–5일)에서 일대일 미팅을 진행하며, 뉴욕에서 열리는 H.C. Wainwright 27th Annual Global Investment Conference(2025년 9월 8–10일)에서는 회사 발표를 진행합니다.
H.C. Wainwright 발표는 2025년 9월 9일 오후 12:00 EDT에 생중계되며, 회사 웹사이트에서 약 90일간 재시청할 수 있습니다.
Milestone Pharmaceuticals (NASDAQ: MIST) a annoncé sa participation à deux prochaines conférences dans le domaine de la santé. Le PDG Joe Oliveto tiendra des rencontres individuelles au Wells Fargo Healthcare Conference à Boston (3-5 septembre 2025) et présentera une intervention d'entreprise au H.C. Wainwright 27th Annual Global Investment Conference à New York (8-10 septembre 2025).
La présentation à H.C. Wainwright sera diffusée en direct sur le web le 9 septembre à 12h00 EDT, avec un replay disponible environ 90 jours sur le site internet de la société.
Milestone Pharmaceuticals (NASDAQ: MIST) gab seine Teilnahme an zwei bevorstehenden Gesundheitskonferenzen bekannt. CEO Joe Oliveto wird Einzelgespräche beim Wells Fargo Healthcare Conference in Boston (3.–5. September 2025) führen und eine Unternehmenspräsentation auf der H.C. Wainwright 27th Annual Global Investment Conference in New York (8.–10. September 2025) halten.
Die Präsentation bei H.C. Wainwright wird am 9. September um 12:00 Uhr EDT live gestreamt; eine Wiederholung steht für etwa 90 Tage auf der Unternehmenswebsite zur Verfügung.
- None.
- None.
MONTREAL and CHARLOTTE, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced President and CEO, Joe Oliveto, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference, to take place September 3 - 5, 2025, in Boston and will provide a corporate update at the H.C. Wainwright 27th Annual Global Investment Conference, to take place September 8 – 10, 2025, in New York.
A webcast of the H.C. Wainwright presentation will be available on September 9 at 12:00 PM EDT. The webcast will be available to watch live and a replay will be available for approximately 90-days following the presentation on the News & Events section of Milestone's website www.milestonepharma.com.
If you are interested in meeting with the Milestone team during the conference, please reach out to your Wells Fargo or H.C. Wainwright representative.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular medicines to benefit people living with certain heart conditions. Milestone recently submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for etripamil for treatment of an abnormal heart rhythm, paroxysmal supraventricular tachycardia or PSVT.
Contact
Investor Relations
Kevin Gardner, kgardner@lifesciadvisors.com
FAQ
When is Milestone Pharmaceuticals (MIST) presenting at the H.C. Wainwright Conference 2025?
Where can I watch Milestone Pharmaceuticals' (MIST) H.C. Wainwright presentation?
Which conferences will Milestone Pharmaceuticals (MIST) attend in September 2025?
How can investors meet with Milestone Pharmaceuticals' (MIST) management team at these conferences?
